• 1
    Belldegrun A, Franklin JR, Figlin R. Commentary on prognostic factors in renal cell carcinoma. J Urol. 1995; 154: 1274.
  • 2
    Giroldi LA, Bringuier PP, Schalken JA. Defective E-cadherin function in urological cancers: clinical implications and molecular mechanisms. Invasion Metastasis. 1995; 14: 7181.
  • 3
    Shimazui T, Giroldi LA, Bringuier PP, Oosterwijk E, Schalken JA. Complex cadherin expression in renal cell carcinoma. Cancer Res. 1996; 56: 32343237.
  • 4
    Shimazui T, Oosterwijk E, Akaza H, et al. Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma. Clin Cancer Res. 1998; 4: 24192424.
  • 5
    Shimazui T, Yoshikawa K, Uemura H, et al. Detection of cadherin-6 mRNA by nested RT-PCR as a potential marker for circulating cancer cells in renal cell carcinoma. Int J Oncol. 2003; 23: 10491054.
  • 6
    Racila E, Euhus D, Weiss AJ, et al. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci U S A. 1998; 95: 45894594.
  • 7
    Beitsch PD, Clifford E. Detection of carcinoma cells in the blood of breast cancer patients. Am J Surg. 2000; 180: 446448.
  • 8
    Hardingham JE, Hewett PJ, Sage RE, et al. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease. Int J Cancer. 2000; 89: 813.
  • 9
    Mclntyre IG, Spreckley K, Clarke RB, Anderson E, Clarke NW, George NJ. Optimization of the reverse transcriptase polymerase chain reaction for the detection of circulating prostate cells. Br J Cancer. 2000; 83: 992997.
  • 10
    Uemura H, Nakagawa Y, Yoshida K, et al. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas. Br J Cancer. 1999; 81: 741746.
  • 11
    McKiernan JM, Buttyan R, Bander NH, et al. The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9. Cancer. 1999; 86: 492497.
  • 12
    Ashida S, Okuda H, Chikazawa M, et al. Detection of circulating cancer cells with von Hippel–Lindau gene mutation in peripheral blood of patients with renal cell carcinoma. Clin Cancer Res. 2000; 6: 38173822.
  • 13
    Shimazui T, Akaza H. Current status of molecular markers in relation to metastasis and prognosis in renal cell carcinoma. Recent Res Dev Cancer. 2002; 4: 625634.
  • 14
    de la Taille A, Cao Y, Sawczuk IS, et al. Detection of prostate-specific membrane antigen expressing cells in blood obtained from renal cancer patients: a potential biomarker of vascular invasion. Cancer Detect Prev. 2000; 24: 579588.